TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Last company where he held a position
TIGENIX SA Socio único
En July de 2019 se produjo la última actualización en el BORME. Se nombró a Takeda Pharmaceuticals International Ag como Socio único.
This company has its headquarters in Madrid and undertakes its business in the investigación y desarrollo experimental en biotecnología... sector.
Featured product:
Director profile
/ without VAT
The report contains
- Executive summary
- Position and company details